A week after CEO Greg Lucier said that Invitrogen plans to expand its presence in the cell-analysis space, the firm announced this week that it has acquired two businesses to do just that.

Invitrogen acquired Quantum Dot and the BioPixels unit of BioCrystal for undisclosed sums, providing the firm with labeling and detection technologies that will add to the portfolio of its Molecular Probes unit and beef up its growing cell analysis business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.